Agilent Technologies (NYSE: A) has received U.S. Food and Drug Administration approval for its PD-L1 IHC 28-8 pharmDx assay as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE